The pharmaceutical landscape is experiencing a development with the arrival of GLP-1 transdermal systems . These exciting formulations offer a potential alternative to providing glucagon-like peptide-1 drugs https://oisikczx449964.mdkblog.com/47086946/glp-1-patches-a-new-way-to-control-diabetes